Literature DB >> 36271074

Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.

Magnus Zethoven1, Luciano Martelotto2, Andrew Pattison2, Blake Bowen2, Shiva Balachander2, Aidan Flynn2, Fernando J Rossello2, Annette Hogg1, Julie A Miller3,4, Zdenek Frysak5, Sean Grimmond2, Lauren Fishbein6, Arthur S Tischler7, Anthony J Gill8,9,10, Rodney J Hicks1, Patricia L M Dahia11, Roderick Clifton-Bligh8,9, Karel Pacak12, Richard W Tothill13,14.   

Abstract

Pheochromocytomas (PC) and paragangliomas (PG) are rare neuroendocrine tumors associated with autonomic nerves. Here we use single-nuclei RNA-seq and bulk-tissue gene-expression data to characterize the cellular composition of PCPG and normal adrenal tissues, refine tumor gene-expression subtypes and make clinical and genotypic associations. We confirm seven PCPG gene-expression subtypes with significant genotype and clinical associations. Tumors with mutations in VHL, SDH-encoding genes (SDHx) or MAML3-fusions are characterized by hypoxia-inducible factor signaling and neoangiogenesis. PCPG have few infiltrating lymphocytes but abundant macrophages. While neoplastic cells transcriptionally resemble mature chromaffin cells, early chromaffin and neuroblast markers are also features of some PCPG subtypes. The gene-expression profile of metastatic SDHx-related PCPG indicates these tumors have elevated cellular proliferation and a lower number of non-neoplastic Schwann-cell-like cells, while GPR139 is a potential theranostic target. Our findings therefore clarify the diverse transcriptional programs and cellular composition of PCPG and identify biomarkers of potential clinical significance.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36271074     DOI: 10.1038/s41467-022-34011-3

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  67 in total

Review 1.  Phaeochromocytoma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer; Massimo Mannelli; Karel Pacak
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

2.  Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.

Authors:  G Eisenhofer; T-T Huynh; K Pacak; F M Brouwers; M M Walther; W M Linehan; P J Munson; M Mannelli; D S Goldstein; A G Elkahloun
Journal:  Endocr Relat Cancer       Date:  2004-12       Impact factor: 5.678

3.  Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.

Authors:  Graeme Eisenhofer; Karel Pacak; Thanh-Truc Huynh; Nan Qin; Gennady Bratslavsky; W Marston Linehan; Massimo Mannelli; Peter Friberg; Stefan K Grebe; Henri J Timmers; Stefan R Bornstein; Jacques W M Lenders
Journal:  Endocr Relat Cancer       Date:  2010-12-21       Impact factor: 5.678

4.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Paragangliomas.

Authors:  Michelle D Williams; Arthur S Tischler
Journal:  Head Neck Pathol       Date:  2017-02-28

5.  Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

Authors:  Montserrat Ayala-Ramirez; Lei Feng; Marcella M Johnson; Shamim Ejaz; Mouhammed Amir Habra; Thereasa Rich; Naifa Busaidy; Gilbert J Cote; Nancy Perrier; Alexandria Phan; Shreyaskumar Patel; Steven Waguespack; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2010-12-29       Impact factor: 5.958

6.  Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.

Authors:  Nelly Burnichon; Laure Vescovo; Laurence Amar; Rossella Libé; Aurélien de Reynies; Annabelle Venisse; Elodie Jouanno; Ingrid Laurendeau; Béatrice Parfait; Jérôme Bertherat; Pierre-François Plouin; Xavier Jeunemaitre; Judith Favier; Anne-Paule Gimenez-Roqueplo
Journal:  Hum Mol Genet       Date:  2011-07-22       Impact factor: 6.150

7.  High incidence of cardiovascular complications in pheochromocytoma.

Authors:  T Zelinka; O Petrák; H Turková; R Holaj; B Strauch; M Kršek; A B Vránková; Z Musil; J Dušková; J Kubinyi; D Michalský; K Novák; J Widimský
Journal:  Horm Metab Res       Date:  2012-04-19       Impact factor: 2.936

8.  HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop.

Authors:  Patricia L M Dahia; Roderick Clifton-Bligh; Anne-Paule Gimenez-Roqueplo; Mercedes Robledo; Camilo Jimenez
Journal:  Endocr Relat Cancer       Date:  2020-08       Impact factor: 5.678

9.  SDH mutations establish a hypermethylator phenotype in paraganglioma.

Authors:  Eric Letouzé; Cosimo Martinelli; Céline Loriot; Nelly Burnichon; Nasséra Abermil; Chris Ottolenghi; Maxime Janin; Mélanie Menara; An Thach Nguyen; Paule Benit; Alexandre Buffet; Charles Marcaillou; Jérôme Bertherat; Laurence Amar; Pierre Rustin; Aurélien De Reyniès; Anne-Paule Gimenez-Roqueplo; Judith Favier
Journal:  Cancer Cell       Date:  2013-05-23       Impact factor: 31.743

10.  A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.

Authors:  Patricia L M Dahia; Ken N Ross; Matthew E Wright; César Y Hayashida; Sandro Santagata; Marta Barontini; Andrew L Kung; Gabriela Sanso; James F Powers; Arthur S Tischler; Richard Hodin; Shannon Heitritter; Francis Moore; Robert Dluhy; Julie Ann Sosa; I Tolgay Ocal; Diana E Benn; Deborah J Marsh; Bruce G Robinson; Katherine Schneider; Judy Garber; Seth M Arum; Márta Korbonits; Ashley Grossman; Pascal Pigny; Sérgio P A Toledo; Vania Nosé; Cheng Li; Charles D Stiles
Journal:  PLoS Genet       Date:  2005-07-25       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.